Tirofiban is superior to aspirin in non-obstructive strokes

Published Date: 08 Mar 2023

Results from the RESCUE BT2 trial showed that among patients with mild or major strokes, more patients taking tirofiban had better 90-day outcomes than aspirin.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Risk of a Second Primary Melanoma Similar Regardless of Race/Ethnicity

2.

Antitumor mRNA-based vaccines show potential against gastric cancer metastasis

3.

Fighting for others: How guilt and obligation drive desire for more intensive treatments in end-of-life cancer care

4.

Navigating breast cancer diagnosis, treatment, and survivorship in Ethiopia

5.

Drop in credit score after cancer diagnosis linked to increased mortality


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot